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Abstract
Background: Esophageal atresia (EA) often leads to persistent esophageal and re-
spiratory symptoms, as well as impaired esophageal and lung function in adulthood. 
The reasons for this, and the connections between symptoms and documented ab-
normalities, are not fully understood.
Purpose:  We wanted to investigate a cohort of adults previously operated on for 
EA in order to describe the prevalence of symptoms and functional abnormalities, as 
well as to investigate whether, and if so how, they are connected.
Methods: Seventy-three of 79 patients operated on for EA in Gothenburg in 1968-
1983 agreed to participate in the first part of the study involving questionnaires re-
lating to symptoms from the esophagus and respiratory tract. Twenty-nine patients 
agreed to undergo further investigations of pulmonary and esophageal function.
Results: From the questionnaire studies, we found that, even though the overall 
quality of life was good, a considerable number of patients had troublesome symp-
toms. Both esophageal and respiratory symptoms were frequent. Fifty-seven percent 
experienced swallowing disturbances (dysphagia) which appeared to be associated 
with regurgitation, which was in turn noted in 40%. Thirty-two percent experi-
enced heartburn. Different respiratory symptoms, such as wheeze and long-standing 
cough (44% and 30% respectively), were much more common in this cohort than 
in the general population. Asthma was reported by 30%, even though no predis-
posing factors were noted. Impaired respiratory function, either obstructive and/or 
restrictive, was noted in 22/28 (79%). The obstruction was mainly in the periph-
eral airways, 17/28 (61%) subjects (measured by multiple-breath inert gas washout, 
MBW), while only six (21%) subjects displayed values indicating central obstruc-
tion. Nine patients had restrictive disease. Airway hyper-responsiveness was frequent 
and associated with atopy and airway inflammation. However, respiratory symp-
toms or doctor-diagnosed asthma (DDA) did not correlate with any specific lung 
function test abnormality. There was a high prevalence of gastro-esophageal reflux 
(GER) measured by pH multichannel intraluminal impedance (pH-MII) involv-
ing both pathological reflux episodes with a pH of < 4 and of > 4 (5/15 and 10/15 
subjects respectively). Dysphagia correlated to the number of weakly acidic reflux 
episodes, while esophageal mucosal damage (14/24 subjects with esophagitis, two of 
whom had Barrett’s esophagus) correlated to the reflux index (RI) and the number 
of episodes of weakly acidic reflux. Lower esophageal sphincter incompetence to 
any extent was frequent (21/24 subjects) and correlated to the number of acid reflux 
episodes and RI. 
Conclusion: A high prevalence of both respiratory and esophageal symptoms re-
mains in adulthood. The impaired pulmonary function appears to be more pro-
nounced than previously described. Even non-acidic reflux episodes appear to con-
tribute to the esophageal morbidity. New investigative modalities such as MBW and 
pH-MII have helped us in further describing and understanding the late sequelae of 
EA. Classical asthma appears to be difficult to diagnose in this patient group. Given 
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the high prevalence of both respiratory and esophageal morbidity, further studies 
and long-term follow-up, including MBW and pH-MII, are warranted.
Keywords: esophageal atresia, long-term outcome, pulmonary function, gastro-
esophageal reflux, dysphagia
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AHR  Airway hyper-responsiveness
ATS  American Thoracic Society
DDA  Doctor-diagnosed asthma
EA  Esophageal atresia
ERS  European Respiratory Society
FEV1  Forced expiratory volume in one second
FVC  Forced vital capacity
GER  Gastro-esophageal reflux
GERD  Gastro-esophageal reflux disease
GerdQ  Gastro-esophageal reflux disease questionnaire
LCI  Lung clearance index
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FENO  Fractional exhaled nitric oxide
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PFT  Pulmonary function test
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PPI  Proton pump inhibitors
QoL  Quality of life
SCC  Squamous cell carcinoma
TEF  Tracheo-esophageal fistula
TLC  Total lung capacity
VACTERL Vertebral, anorectal, cardiac, trachea-esophageal, renal, limb
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Introduction
Introduction
Esophageal atresia (EA) is a congenital malformation which was first described in 
the 17th century, but it took almost 300 years before it could be corrected. Initially, 
the postoperative mortality was high, but, due to advances in pediatric and cardiac 
surgery, as well as improved intensive care, the overall survival rates nowadays ex-
ceed 90% (1, 2). Today, interest focuses on the long-term outcome, with special em-
phasis on esophageal and respiratory symptoms, as they have been shown to follow 
the patients into adulthood (3). The main esophageal symptoms are gastro-esoph-
ageal reflux (GER) and dysphagia (4, 5), while the respiratory problems are due to 
pulmonary impairment leading to both restrictive and obstructive patterns (6, 7, 8).
The reasons for both the esophageal and pulmonary impairments are multifactorial 
and not fully understood, but they appear to affect the quality of life (4, 8). The cor-
relation between symptoms and the results of clinical investigations, when it comes 
to both the esophagus and the lungs, has not been consistent. There are probably 
many reasons for this. One of them, at least when it comes to dysphagia, might be 
the lack of a uniform definition.  
For unknown reasons, there also appears to be an over-representation of doctor-
diagnosed asthma within this patient group (7, 8, 9). Taken together, the above-
mentioned reasons might contribute to the fact that there are no clear guidelines on 
how these patients should be monitored through life. Further studies designed to 
produce a better understanding of the symptoms and clinical findings are needed to 
answer this question.
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Background data Esophageal atresia
History
The first description of esophageal atresia was given in 1670, when, in a paper en-
titled Description of A Monstrous Birth in Plymouth, William Durston described how 
he was called to the delivery of conjoined twins, one of whom had esophageal atre-
sia. In 1697, Thomas Gibson was the first to describe esophageal atresia with a distal 
fistula, which is the most common type (10).
It would take almost two and a half centuries, 1939, before the first survivors were 
recorded, using a staged approach performed independently by Dr William Ladd 
(11) in Boston and Dr Logan Leven (12) in Minnesota. Two years later, Dr Cameron 
Haight performed the first successful primary repair (13) and, in 1947, Dr Philip 
Sandblom performed the first operation in Sweden (14).
Embryology and etiology
The differentiation of the early foregut into the esophagus and trachea takes place 
in the fourth week of gestation. There is still controversy about how this is done, 
but there are two main theories (15). The first theory proposes that the formation 
of a tracheal diverticulum takes place from the primitive digestive tube, which then 
grows rapidly in the caudal direction, resulting in the separation of the trachea and 
esophagus. In the second theory, the trachea-esophageal foregut tube is separated 
by the formation of lateral epithelial ridges which meet and fuse in the midline in a 
cranial direction. The exact pathway is not known, but failure to make this separa-
tion complete results in EA. 
Following the introduction of an experimental model, which induces EA and the 
same spectrum of associated malformations in rodents, there is now a way to look 
for possible etiological mechanisms (16). This model has helped demonstrate an 
inherent abnormality of the neurological supply of the esophagus, as well as a delay 
in the innervation of the respiratory tract (17, 18). It has also been shown that experi-
mentally induced EA is accompanied by tracheobronchial malformations, including 
tracheomalacia, and also by delayed tracheobronchial branching, indicating a close 
relationship between EA and affected pulmonary function (19, 20, 21). The current 
opinion is that the etiology of EA malformation is multifactorial and probably in-
volves both genetic and/or environmental factors (22, 23).
Epidemiology
EA, which is the most common congenital malformation of the esophagus, has 
been described as having an incidence of between 3-4/10,000 newborns (24, 25). A 
slight male predominance and a higher frequency of twinning have been shown in 
the EA group. The malformation is also more common among Caucasians and with 
increased maternal age (26, 27, 28).
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Anatomy and classification
There have been different classifications over the years. The first classification was 
made by a radiologist named Vogt in 1929 (29). In 1953, Gross made his classifica-
tion, which is probably the most used worldwide nowadays (30). Kluth presented the 
most detailed classification in 1976 (31).
The five main types and incidences according to Gross are presented below (Figure 1). 
 A 7%
Isolated EA
B 1% 
EA with
proximal fistula 
(TEF) 
C 86%
EA with 
distal TEF
D 2%
EA with 
proximal and 
distal TEF
E 4%
Only TEF
(H-type)
Figure 1. Classification according to Gross.
In addition to the above-mentioned anatomical classification, patients with EA can 
also be divided into different risk classification groups. In 1962, Waterston made the 
first classification, which took account of birth weight, pneumonia and associated 
malformations (32). Different risk classifications have followed (33, 34, 35) and the 
one proposed by Spitz, involving birth weight and cardiac anomaly, is probably the 
most commonly used nowadays. Despite recent contributions, Waterston’s classifica-
tion has still been shown to have prognostic relevance (36).
Associated anomalies
Associated anomalies occur in 40-50% of cases, where the majority involve one 
or more of the VACTERL (vertebral, anorectal, cardiac, tracheo-esophageal, renal 
and limb) associations (25, 37). VACTERL (38) is an acronym which is used when 
two or more of the previously mentioned malformations are present in association 
with the esophageal atresia. The most commonly associated malformations are in 
the cardiovascular system, 22-32% (2, 39), followed by the genitourinary, anorectal 
and gastrointestinal system, each of which is seen in about 15% (2, 37). Associated 
chromosomal abnormalities occur in about 5% of EA children (25, 38). Associated 
anomalies are most common in cases of EA without TEF and least common in cases 
with isolated TEF (H-type) (37).
Diagnosis
EA is difficult to diagnose prenatally and, as a result, most of the cases that are born 
are undiagnosed. The absence of a stomach bubble together with polyhydramniosis 
are two non-specific prenatal signs which might arouse suspicion (40, 41), but the 
positive predictive value has unfortunately been shown to be 56% at best (40). How-
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ever, some authors propose that these signs should lead to the further identification 
of chest and neck anatomy by ultrasound in order to look for the upper esophageal 
pouch, which, if found, has been shown to have a positive predictive value of 100% 
(42). 
Once born, the diagnosis might be suspected if the child has excessive salivation and 
regurgitates or chokes and coughs in conjunction with the first feed. The inability to 
pass a catheter into the stomach strongly suggests the diagnosis and, by performing 
a plain X-ray with the catheter in place, the diagnosis is often confirmed.
It is desirable to determine the type of atresia before surgery, since this determines 
the initial surgical approach. Air in the stomach and abdomen confirms the presence 
of a distal fistula, while the absence of air in the gastrointestinal tract raises the sus-
picion of an isolated esophageal atresia. In the event of a fistula between the trachea 
and esophagus, without any atresia, so-called H-type, the diagnosis is often delayed 
and suspected after recurrent respiratory infections and/or coughing and choking 
during feeding. Bronchoscopy, together with esophagoscopy, are often required to 
confirm the diagnosis of this latter type.
Preoperative treatment
The patient should be placed in the supine position with the head elevated, while a 
suction catheter should be placed in the upper esophageal pouch in order to prevent 
aspiration. 
Even though there is no consensus on preoperative medication, both antibiotics and 
acid suppression could be used in order to reduce the risk of preoperative complications.
Preoperative screening for associated anomalies with special emphasis on renal and 
cardiac anomalies, including the determination of the side of the aortic arch, is 
nowadays performed at most centers (43, 44).
Many centers also perform a preoperative bronchoscopy in order to localize the fis-
tula or any other structural abnormality which might influence the planning or 
outcome of surgery (43, 45, 46).
Surgery
The exact surgical approach depends on the type of EA. The most common type, i.e. 
EA with a distal fistula, is operated on using a right-sided thoracotomy.
Even though thoracoscopy made its appearance in 1999 (47) and has attracted in-
creasing interest during the last decade, there is still a lack of convincing data to 
indicate whether this actually benefits the patient more than conventional thora-
cotomy, which must still be regarded as the gold standard (48, 49). 
If the aortic arch is right-sided, as seen in around 3%, (50, 51), some authors rec-
ommend considering a left-sided thoracotomy (50, 52).  Others state that a con-
ventional right-sided thoracotomy should be performed, when possible, irrespective 
of the site of the aortic arch (51, 53). In order to preserve muscle and innervation, 
some alternative skin incisions have been proposed (54, 55). The entrance into the 
thoracic cage is between the fourth and fifth ribs and an extra-pleural approach is 
often made to obtain access to the atresia. In most cases, it is feasible to perform a 
primary anastomosis between the two ends (Figure 2), even though some lengthen-
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ing of the proximal pouch might be considered in some cases in order to reduce ten-
sion (56, 57). The long- or wide-gap esophageal atresia poses a greater challenge for 
the pediatric surgeon. Even though there is no consensus on the exact definition of 
long-gap EA, or how to measure the length between the two ends, the main problem 
is that the distance between the two ends is too long to make a primary anastomosis. 
In the event of an isolated esophageal atresia, this can be suspected and prepared 
for by initiating the surgery through the abdomen in order to measure the gap. A 
fistula must always be closed, but, if for any reason, the primary anastomosis cannot 
be performed, the patients should be given a gastrostomy for feeding while the two 
esophageal ends are left in place. This “wait-and-see” staged repair is preferred by 
most surgeons, even though some advocate a staged esophageal lengthening by trac-
tion during the process (58), a technique which has, however, been questioned due 
to reproduction difficulties (59).
Trachea
Proximal 
esophagus
Anastomosis Distal esophagus
Fistula
Figure 2. Esophageal primary anastomosis.
During the wait, the distance between the two gaps is measured radiologically at 
regular intervals and a delayed primary anastomosis might be attempted when the 
gap has narrowed sufficiently. It has been suggested that, if the gap persists after 12 
weeks, the need for an esophageal replacement should be considered (60). When-
ever delayed primary repair is not successful, there are different options regarding 
esophageal replacement, such as jejunal or colonic interposition (61, 62), gastric 
transposition (63) or different types of gastroplasty (64, 65, 66). As all techniques 
have their pros and cons, there is no consensus on which is to be preferred (59, 67) 
and the procedure of choice is often linked to what the surgeon is comfortable with. 
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The isolated H-type fistula is often operated on through the neck using a cervical 
approach, even though some cases require a right-sided thoracotomy.
Outcome
Survival
Overall survival nowadays is more than 90% (1, 2). In the past, mortality was mostly 
associated with cardiac malformations, prematurity, respiratory complications and 
infections. Advanced intensive care and cardiac surgery are the main reasons for this 
progress. One recent study illustrates this in a clear way by comparing two adjacent 
time periods. Despite a higher frequency of low birth weight and major cardiac de-
fects in the latter group, the overall survival rate increased (1). 
Early morbidity
The most common reported early complications are anastomotic leak, stricture and 
recurrent fistula.
An esophageal anastomotic leak is the earliest complication reported in 7-25% (1, 2, 
68). The leak is usually due to anastomotic tension, but the surgical procedure may 
also be responsible (68). Minor leaks can usually be managed conservatively with a 
chest drain, the suspension of oral feeding and antibiotics, while major leaks, which 
usually occur within 48 hours (37), often require surgical intervention.
The incidence of anastomotic strictures varies widely, due to the lack of a uniform 
definition, but a need for dilatation has been noted in up to 80% (1, 2). Nowadays, 
dilatation is often performed using endoscopic balloon dilatation and anastomotic 
stricture resection is only needed in a few percent (2, 43, 69).
In recent studies, a recurrent fistula is reported in 2-8% (1, 2, 43, 69) and is often 
present with respiratory symptoms during feeding. The fistula can be closed either 
by surgery or using different endoscopic techniques (70, 71).
Late morbidity
Esophageal morbidity is mainly due to gastro-esophageal reflux and dysphagia. 
Dysphagia is reported in up to 85% of survivors (5, 72, 73, 74). The main cause can 
probably be attributed to disturbed esophageal motility, innate or iatrogenic, but 
gastro-esophageal reflux and esophageal stricture must also be ruled out.
Gastro-esophageal reflux is almost as common and is reported in up to 63% of pa-
tients operated on for EA (5, 75, 76). Esophageal dysmotility, together with changes 
in the anatomy of the gastro-esophageal junction, are regarded as the main causes 
(77). Conservative treatment is quite often not sufficient, due to the complex nature 
of GER in this patient group, and the proportion of patients requiring fundoplica-
tion ranges from 10% to 50% (77).
The high prevalence of GER in turn leads to a high prevalence of esophagitis. This 
might lead to metaplasia in the esophagus, Barrett’s esophagus, which has been 
reported in up to 36% of EA survivors (78). The difference in the way Barrett’s is de-
fined might explain the fairly wide prevalence range and there is still no universally 
accepted consensus on this matter (79). Barrett’s is in turn a well-known risk factor 
for adenocarcinoma (80), which has so far been reported in three patients undergo-
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ing surgery for EA. Seven cases of squamous cell carcinoma (SCC) have also been 
reported in this patient group, all at an age around 40, which raises the question of 
whether the risk increases further with age (81). The pathogenesis of SCC in patients 
with EA is uncertain. However, the association between EA and the risk of esopha-
geal cancer has been questioned (25, 82), but a longer follow-up is warranted before 
such a correlation can be ruled out or definitely established. 
Respiratory morbidity is fairly common following EA repair. Both respiratory symp-
toms and pulmonary function test abnormalities are more common than in the 
general population. The cause is probably multifactorial, including both congeni-
tal causes, such as pulmonary hypoplasia and tracheomalacia, and acquired causes, 
such as GER, leading to recurrent aspiration and the postoperative restriction of 
the thoracic cage (83). Long-term follow-up studies have reported both restrictive 
and obstructive abnormalities (6, 7, 8). Symptoms including wheeze, long-standing 
cough and repeated respiratory infections are common and, even though it has been 
stated that there is an improvement over time, many patients have symptoms per-
sisting into adulthood (8, 76, 84). A higher incidence of doctor-diagnosed asthma 
(DDA) has also been reported compared with the general population (8). The reason 
for this is not known, but there is perhaps a tendency to over-diagnose asthma in this 
population, because respiratory symptoms mimicking asthma in EA patients may be 
due to other causes (6).
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General background data regarding the 
esophagus and the lungs
Esophagus
The esophagus is a hollow organ which transports food to the stomach, mainly by 
peristalsis mediated by both intrinsic and extrinsic innervation. The distal part has 
a valvular function which prevents food and liquid from re-entering the esophagus 
once they reach the stomach. It may also, as a result of relaxation, serve as a safety 
valve in order to evacuate excessive swallowed air. 
The lower esophageal sphincter (LES), together with the crural diaphragm and the 
anatomical flap valve, serve as this anti-reflux barrier, protecting the esophagus from 
prolonged exposure to acidic content from the ventricle. Moreover, esophageal peri-
stalsis is an important factor when it comes to protection from GER. Mechanisms 
or events that affect these defensive mechanisms, such as an increased gastro-esoph-
ageal pressure gradient, can exacerbate the reflux. Obesity, male gender and increas-
ing age have all been associated with both GER and Barrett´ s esophagus. The action 
when it comes to the way GER induces epithelial injury is complex and not fully 
understood. 
Gastro-esophageal reflux
GER is common in the general population. Episodes of the reflux of gastric con-
tent to the esophagus may occur in healthy subjects, in relation to the transient 
relaxation of the lower esophageal sphincter after meals to release swallowed air, 
for example, and can thus be regarded as a physiological event. Gastro-esophageal 
reflux disease (GERD), on the other hand, is defined as reflux that causes trouble-
some symptoms, mucosal injury to the esophagus or both (85). The main symptoms 
are heartburn and regurgitation. In the western world, an approximate prevalence of 
10-20% of GERD, defined by at least weekly heartburn and/or acid regurgitation, 
has been observed (86).  In addition to the effect on the esophagus, which can lead 
to severe esophagitis and intestinal metaplasia (Barrett’s esophagus), GERD might 
also cause extra-esophageal problems such as hoarseness, coughing and asthma. 
Since the diagnosis is based on symptoms and/or histological findings, there is no 
universal diagnostic method, even though endoscopy with biopsies, proton-pump 
inhibitor tests and ambulatory pH monitoring are often used in order to evaluate 
the presence of GER. 
The treatment of gastro-esophageal reflux is often conservative, including lifestyle 
and dietary modifications. Medication with antacids or acid inhibition (PPI) might 
help, even though they do not provide any definite solution. If troublesome symp-
toms persist in patients with proven GERD, or if patients are reluctant to use PPI for 
the rest of their lives, surgery could be considered as a last option.
Barrett’s esophagus
Barrett’s esophagus is a condition in which metaplastic columnar epithelium, which 
predisposes to cancer development, replaces the stratified squamous epithelium that 
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normally lines the distal esophagus (87). It is not known why columnar epithelium 
replaces the squamous epithelium. There is no consensus on whether or not any type 
of columnar epithelium, i.e. gastric fundic-, cardia- or intestinal type, sampled from 
the tubular esophagus should be recognized as Barrett’s esophagus. The British and 
US guidelines disagree on whether or not the histological diagnosis must include 
intestinal metaplasia (87, 88) The prevalence of Barrett’s esophagus in the general 
population has been reported to be 1.3-1.6% in two population-based studies (89, 90). 
The association between Barrett’s esophagus and adenocarcinoma has been estab-
lished since the 1970s and it is believed to develop through the metaplasia-dysplasia-
carcinoma sequence.
Dysphagia
Dysphagia is also a symptom that occurs in the general population. It involves dif-
ficulty swallowing and is a condition which increases with age and is reported by 
5-8% of the general population aged 50 years and over (91). Typically, the patient 
describes food being “held up” retrosternally or in the neck, but atypical symptoms, 
such as meal-related regurgitations and a sense of fullness retrosternally, can also 
be reported. One of the main questions is whether the patient actually has dyspha-
gia, as a globus sensation and odynophagia (pain on swallowing), for example, can 
sometimes be misinterpreted as dysphagia. Dysphagia can be caused by a variety of 
disorders (neuromyogenic, structural or motility based), from the oropharyngeal 
region all the way down to the lower esophageal sphincter. When it comes to sus-
pected esophageal dysphagia, the most valuable and commonly used investigations 
are endoscopy, esophageal manometry and a barium-swallow study. The treatment 
strategy depends on the cause. 
Lungs
To understand the information that is received from different lung investigations, 
a knowledge of the structure and development of the airway system is mandatory. 
Lung development begins in the fourth week of gestation, as a ventral diverticulum 
from the foregut, and starts branching dichotomously with each airway dividing 
into smaller airways. In this way, the cross-sectional area of the airways in total 
is successively increased against the periphery, which means a reduction in airway 
resistance. This leads to the peripheral airways, less than 2 mm in diameter, which 
represent about 90% of the total lung volume, only contributing to about 10% of 
the total airway resistance (92). Alveolarization continues to the age of three at least, 
after which further lung growth occurs as a result of increasing alveolar size. The 
respiratory system is divided into elements of air conduction and air exchange. The 
conductive part (airway generation 0-16) leads the oxygen to the acinar part (airway 
generation 17-23) where the gas exchange takes place (Figure 3). Development of the 
lung is controlled genetically, but it can be influenced by both pre- and postnatal 
factors. 
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Asthma
Asthma is the most common chronic disease among children and young adults. 
Even though there is no clear consensus on how to define asthma, it includes a het-
erogeneous group of conditions that are characterized by recurrent episodes of air-
way obstruction, which reverse either spontaneously or after using medication. The 
etiology is complex, involving both genetic and environmental factors. The symp-
toms include wheeze, chest tightness, breathlessness and cough. Asthma is usually 
connected with bronchial hyper-responsiveness and evidence of chronic airway in-
flammation. In young adults, asthma is often associated with the presence of allergic 
sensitization or eczema.  This means that asthmatic individuals often have positive 
allergy screening test, fractional exhaled nitric oxide (FENO) and bronchial hyper-
responsiveness tests.
The prevalence globally of doctor-diagnosed asthma in an adult population aged 
18-45 has been estimated to be 4.3%, but with a range between 0.2-21% (93). A 
recent Swedish study found that the overall prevalence of doctor-diagnosed asthma 
in a population aged 16-75 years was 8.3% (94). In the age groups of 26-35 years 
and 36-45 years, the prevalence of doctor-diagnosed asthma was 10.2% and 8.4%, 
respectively. The first symptoms usually occur during the preschool years, but many 
of these children do not develop chronic asthma. There is currently no established 
Figure 3. Schematic presentation of the dichotomic dividing structure of the airway tree.
Peripheral
airways
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strategy for the primary prevention of asthma and the two most important aspects 
of asthma therapy are pharmacological therapy and environmental therapy. The cor-
nerstones of asthma medication are bronchodilators (beta-2-agonists) and inhaled 
corticosteroids. 
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Aims
Aims
The aims of this study were:
•	 to describe the occurrence of respiratory symptoms in adulthood among patients 
who underwent surgery for EA, compared with the presence of the symptoms 
in the general population
•	 to investigate the prevalence of dysfunction of the peripheral airways, as 
indicated by a raised lung clearance index (LCI),  and whether a raised LCI 
is associated with respiratory symptoms. In addition, the aim was to evaluate 
whether the asthma diagnosis is accurate
•	 to measure dysphagia following esophageal atresia quantitatively and, by doing 
so, investigate whether dysphagia  correlates with early risk factors, symptoms 
of GER and quality of life (QoL)
•	 to introduce pH multichannel intraluminal impedance (pH-MII) to evaluate 
the prevalence of GER in an adult group of patients who underwent surgery 
for esophageal atresia as newborns and to evaluate the association between 
esophageal symptoms and the results of pH-MII. In addition, we aimed to 
investigate whether pH-MII could improve the identification of risk factors for 
changes in esophageal histology, i.e. esophagitis and Barrett’s esophagus
26
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Patients
Patients
Between 1968 and 1983, 110 patients underwent surgery for EA at the Children’s 
Hospital in Gothenburg. Eighty (43 men and 37 women) of the 110 patients were 
still alive and 79 were located through the Swedish Population Register Center. The 
hospital records were reviewed for clinical data: gender, birth weight, type of atresia, 
associated malformations, anastomotic tension (as reported by the surgeon), post-
operative complications including anastomotic stricture, re-operations and, finally, 
the need for anti-reflux surgery. Twenty-eight (35%) patients had associated malfor-
mations. A diagnosis of VACTERL (vertebral, anorectal, cardiac, tracheo-esopha-
geal, renal and limb), defined as the presence of three or more associated malforma-
tions, was made in seven patients. The clinical characteristics are shown in Table 1.
Table 1. Clinical characteristics of survivors undergoing surgery for esophageal atresia in 
Gothenburg 1968-1983 (n=79).
Gross
type A
(n=3)
Gross 
type B
(n=1)
Gross 
type C
(n=69)
Gross 
type D
(n=1)
Gross 
type E
(n=5)
Surgical procedure
Primary anastomosis 1 69 1 5
Delayed primary anastomosis 1 1
Colonic interposition 1
Associated anomalies
Congenital heart disease 6 1
Gastrointestinal 9
Urogenital 5
Musculoskeletal 8
Chromosomal 1
CNS† 2
Complications
Stricture 3 16
Recurrent TEF‡ 2
Leak 2 1 7
Re-operation due to stricture, 
leakage or re-fistulation
1 11
†CNS, central nervous system ‡TEF, trachea-esophageal fistula
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In the spring of 2008, the located 79 patients were contacted with a letter describing 
the studies. Of the 79 patients, 73 (92%) completed the questionnaires on esopha-
geal (Paper 1) and respiratory (Paper 2) symptoms. In order to make the study group 
in the esophageal questionnaires (Paper 1) as homogeneous as possible, we chose to 
focus the further analysis in this paper on those patients representing the vast ma-
jority: Gross type C (63 patients). Twenty-nine of these sixty-three (46%) patients 
agreed to undergo further testing of their respiratory (Paper 3) and esophageal (Pa-
per 4) function (Figure 4).
Figure 4. Flow chart of patients operated for esophageal atresia in Gothenburg between 
1968 and 1983.
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Methods
Questionnaires     
Dysphagia score (Papers 1 and 4)
The numerical dysphagia score is composed of 9 items of food with different viscosi-
ties and solidities. The score was originally constructed by Dakkak et al. as an in-
strument transforming symptoms of dysphagia into a numerical score, with obvious 
advantages regarding its use in the evaluation of clinical trials, and also to be used 
as a convenient tool in clinical practice (95). Initially, a score of 45 was regarded as 
no difficulty swallowing. The score has since been reversed by Watson et al., so that 
the numerical score increases with the severity of the dysphagia. As a result, score 
45 now means severe dysphagia (96), which is the score used in our study (Table 2).
Table 2. Dysphagia score.
      Dysphagia score
      Due to swallowing difficulties, I have problems:
Gastro-esophageal reflux score (Papers 1 and 4)
The gastro-esophageal reflux disease questionnaire (GerdQ) was developed as a tool 
 Never Sometimes Always 
 
Drinking water 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Drinking milk 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Eating yoghurt 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Eating jam or jelly 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Eating mashed potatoes or scrambled eggs 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Eating boiled vegetables or fish 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Eating bread 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Eating fresh fruit 
 
 
⁯ 
 
⁯ 
 
⁯ 
 
Eating meat 
 
 
⁯ 
 
⁯ 
 
⁯ 
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for the diagnosis and management of gastro-esophageal reflux disease in primary 
care. It has a seven-day time frame and the questions are derived from previously 
validated instruments (97). Two of the questions, regurgitation and heartburn, were 
used in our calculations, as they have been shown to have the strongest correlation 
to GER. 
Quality of Life (QoL)(Paper 1)
The SF-36v2™ measures 8 components of health and also yields two summary com-
ponent scores describing physical and mental health. In this study, we used the 
Swedish version of the SF-36v2™ (QualityMetric Inc., Lincoln RI, USA).  The Swed-
ish version has been shown to have good reliability and validity (98). For compari-
son with patient data, an age- and gender-matched reference sample was randomly 
selected from the Swedish SF-36v2 population database (98). 
Respiratory symptoms (Papers 2 and 3)
These questions were based on the Swedish OLIN (Obstruktiv Lungsjukdom i Nor-
rbotten, Obstructive Lung Disease in Northern Sweden) questionnaire that has 
been used in several studies of obstructive lung disease in Northern Europe (99). 
The questionnaire contained questions on obstructive respiratory disease, respira-
tory symptoms, rhinitis and possible risk factors for disease, such as smoking and 
a family history of asthma or allergy (Appendix 1). As controls, 4,979 gender- and 
age-matched subjects from the same geographical region were used (Paper 2).
All patients were also asked about weight, height, medication and other diseases.
Pulmonary function tests (PFTs) (Paper 3)
SF6 multiple-breath inert gas washout (SF6 MBW)
The presence of impaired peripheral airway function was measured by SF6 multiple-
breath inert gas washout (SF6MBW). This was performed in triplicate and according 
to existing recommendations (100, 101)(Figures 5 and 6). 
During the wash-in phase, a dry gas mixture containing 4% SF6, 4% helium (He), 
21% oxygen (O2) and balance nitrogen (N2) was administered. Wash-in continued 
until inspiratory and expiratory SF6 concentrations were stable and equal, including 
an additional 30 seconds, after which washout was initiated. Washout continued un-
til the end-tidal SF6 concentration was below 1/40th of the starting concentration. 
The lung clear index (LCI), a marker of ventilation distribution inhomogeneity, was 
calculated as the number of lung volume turnovers required to reduce the end-tidal 
SF6 concentration to less than 1/40th of the initial concentration. The mean value of 
three LCI recordings in each subject was reported and expressed as z-scores, which 
were derived from the predicted LCI values and residual standard deviations (RSD) 
from a matched group of 33 healthy controls. If the intra-session variability of LCI 
values was large (coefficient of variation > 5%), the most deviant value was excluded 
and the mean LCI was based on the two remaining recordings. 
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Figure 5. Subject performing a washout. The supply of wash-in gas is provided by the 
cylinder in the background. A gas analyser is used to measure flow and SF6 concentration 
and expiratory volume is displayed to the subject on a separate screen.
Figure 6. Wash-out phase as displayed on the monitor during the investigation.
Spirometry
Spirometry was performed according to American Thoracic Society (ATS)/Euro-
pean Respiratory Society (ERS) standards (102). The results were compared with 
predicted values using the new global “all ages” reference values presented by Stano-
jevic et al. (103). FEV1, FVC and FEV1/FVC ratios were recorded. A low FEV1/FVC 
(z-score <-1.96) was interpreted as evidence of an obstructive ventilatory defect. 
Whole-body plethysmography
Total lung capacity (TLC) was measured by whole-body plethysmography accord-
ing to current ATS/ERS standards (104). TLC z-scores of < -1.96 were interpreted as 
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evidence of a restrictive ventilatory defect. For whole-body plethysmography, Swed-
ish reference values were used (105, 106).
All the subjects inhaled 400 mcg of salbutamol following the pulmonary function 
tests and an increase in FEV1 of at least 12% above the initial value, following bron-
chodilation medication, was taken as evidence of reversible airway obstruction.
Findings of an abnormally reduced FEV1/FVC ratio in combination with TLC and 
LCI within normal limits were used to indicate the presence of an isolated central 
airway obstruction, while the finding of an abnormally raised LCI in combination 
with an FEV1/FVC ratio and TLC within normal limits was used to classify the 
defect as an isolated peripheral airway obstruction. 
Allergy test, FENO and bronchoreactivity (Paper 3)
Allergy test
The UniCAP-PhadiatopTM assay was used to determine the presence of allergic sen-
sitisation. This test is a qualitative serological test that reveals the presence of serum 
IgE antibodies to the most common allergens in Scandinavia: birch, timothy and 
mugwort pollens; cat, dog and horse dander; house-dust mites and mould allergen. 
A positive PhadiatopTM result was used to indicate the presence of an atopic pheno-
type.
Fractional exhaled nitric oxide (FENO)
As a marker of airway inflammation, FENO was measured in accordance with the 
ATS recommendations (107). Reported values are the mean concentrations calcu-
lated from three measurements that agree within 10%. Previously reported FENO 
reference values were used, taking age and height into account (108).
Methacholine challenge
The presence and severity of airway hyper-responsiveness (AHR) was determined 
by a direct bronchial methacholine challenge, which was performed using a tidal 
volume-triggered dosimetric method. It was performed in all subjects whose baseline 
FEV1 was above 60% of predicted values. Medication which could potentially affect 
AHR assessment was discontinued and patients were asked to refrain from tea, cof-
fee or Coca-Cola within four hours prior to investigation. The subjects were to be 
free of any viral respiratory infection or asthma exacerbation requiring oral steroids 
during the two-week period preceding the test. Methacholine was inhaled in subse-
quently increasing doses at intervals of at least one minute until FEV1 had decreased 
by 20% or more compared with baseline, or when a cumulative dose of 5.825 mg 
had been given. The provocative dose of methacholine resulting in a 20% fall in 
FEV1 (PD20FEV1) was calculated by linear interpolation. The subjects were divided 
into four AHR severity groups based on the challenge results: PD20FEV1 < 100 mcg 
was regarded as evidence of severe AHR, 100-500 mcg as moderate, 500-2,000 mcg 
as mild AHR and > 2,000 mcg as the absence of AHR.
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Esophageal examinations (Paper 4)
pH multichannel intraluminal impedance (pH-MII)
pH-MII was used to detect GER episodes, irrespective of pH. During the time of 
registration, the study subjects were instructed to record the time of meals, the time 
spent in the supine position and symptoms as they occurred. They were also in-
structed to maintain normal daily living but to avoid alcohol, carbonated beverages, 
food with a low pH and previously mentioned medications.
A six-segment impedance catheter was used and the pH electrode within the cath-
eter was positioned 5 cm above the manometrically determined lower esophageal 
sphincter. The data were recorded for 24 hours and then transferred to a computer 
for analysis. The result was also reviewed and edited manually by one independent 
investigator for bolus events.
Reflux events were characterised by impedance, while their acidity was characterised 
by simultaneous pH monitoring. A reflux episode was defined as retrograde bolus 
movement in at least two consecutive recording channels. The evaluated variables 
were as follows.
1. Number of acid (pH<4), weakly acidic (pH 4-7) and weakly alkaline (pH>7) 
reflux episodes. The number of acid reflux >55, weakly acidic reflux >26 or 
weakly alkaline reflux >1 episodes were regarded as pathological (109).
2. The reflux index (RI) was defined as the percentage of investigated time  
with esophageal pH of < 4. An RI of > 4.2% was regarded as pathological (110).
3. Bolus exposure (BE) was defined as the percentage of investigated time with 
reflux, irrespective of the pH level. A BE of > 1.4% was defined as pathological (109).
Esophageal manometry
Esophageal manometry was carried out with a transnasally placed 8-lumen manom-
eter catheter perfused with water at a constant rate of 0.5 ml/minute with a low-
compliance perfusion system. Esophageal pressure characteristics were transferred 
to a polygraph and transformed to a computer for graphic calculation and analysis.
The location of the gastro-esophageal junction was determined using stepwise with-
drawal through the high-pressure zone. The basal pressure of the lower esophageal 
sphincter (LES) was measured during end expiration using the stationary pull-
through technique (111).
The subjects performed 10 wet swallows with 5 ml of room-tempered tap water with 
an interval of at least 20 seconds between each swallow. The mean amplitude of 
the contraction waves was calculated. The occurrence of simultaneous contractions, 
failed peristalsis or non-propagating contractions was then compiled.
An LES basal tonus of < 10 mm Hg was regarded as hypotonic, while < 30 mm Hg 
in the distal esophagus, calculated as the average pressure of 10 wet swallows, was 
regarded as a low-pressured esophagus (112).
All the manometric examinations were performed and analyzed by one investigator.
Upper gastrointestinal endoscopy
The patients were prepared with an overnight fast and the procedure was performed 
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under locally applied mucosal anesthetics, without sedation, with the patient placed 
in a left lateral position. 
During the investigation, special emphasis was placed on the following findings: 
macroscopic esophageal strictures, function of the lower esophageal sphincter, iden-
tification of the esophago-gastric junction and presence of mucosal lesions in the 
esophagus and in the vicinity of the cardia region. 
Biopsies were retrieved from predefined locations and additional biopsies were taken 
if other mucosal lesions were seen. Biopsy specimens were fixed in 10% buffered 
formalin. All cases with macroscopic esophageal inflammatory lesions (esophagi-
tis) were classified in accordance with the LA classification (A-D) (113). Barrett’s 
esophagus was suspected endoscopically if a columnar lined esophageal epithelium 
occurred above the esophago-gastric junction. All endoscopies were performed by 
the same experienced adult gastroenterologist.
Histology
For histology, eosin and alcian blue periodic acid-Schiff double staining were used. 
Esophagitis was graded according to Ismail-Beigi et al. (114). Barrett’s esophagus was 
defined as intestinal metaplasia with goblet cells in the tubular esophagus. All samples 
were analyzed by a single pathologist specializing in the gastrointestinal tract.
Statistical methods
Continuous variables were described using the mean, standard deviation (SD), me-
dian and range, while categorical variables were described with n and %.
For comparisons between two groups, Fisher’s exact test was used for dichotomous 
variables and the Mann-Whitney U-test for continuous variables. Mantel-Haenszel's 
exact test was used for ordered categorical variables, while the chi-square exact test 
was used for non-ordered categorical variables.
Correlations between the dysphagia score and SF-36 scales and continuous variables 
were calculated using Spearman’s correlation (Paper 1). Gastro-esophageal reflux 
symptoms which could predict dysphagia were investigated using multiple stepwise 
regression analysis and the association was described by odds ratios and 95% confi-
dence intervals (Paper 1).
Odds ratios (OR) with 95% confidence intervals (CI) were calculated from 2x2 
contingency tables using standard methods (Paper 2).
For comparisons involving more than two groups, the Mantel-Haenszel chi2 test was 
used for ordered categorical variables, while Spearman s´ rank correlation test was 
used for continuous variables (Paper 3).
For comparisons involving more than two groups, the Mantel-Haenszel chi2 test was 
used for ordered categorical variables, while the Jonckheere-Terpstra test was used 
for continuous variables (Paper 4).
All significance tests were two-tailed and conducted at the 0.05 significance level.
Ethical approval
The studies were approved by the ethics committee at the University of Gothenburg.
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Results
Respiratory symptoms and airway function (Papers 2 and 3)
Seventy-three of 79 patients (92%) completed the questionnaire on respiratory 
symptoms (Paper 2). Respiratory symptoms were consistently more common among 
EA patients than controls (Table 3).
Table 3. Respiratory symptoms among 73 adult subjects operated on for esophageal atresia.
Variable EA
n (%)
Controls
n (%)
p-value
Doctor-diagnosed asthma 22 (30.1%) 477 (9.6%) <0.0001
Asthma medication 17 (23.9%) 432 (8.7%) 0.0002
Cough with sputum production 25 (34.2%) 633 (12.7%) <0.0001
Long-standing cough 22 (30.1%) 573 (11.5%) <0.0001
Wheezing last 12 months 32 (44.4%) 825 (16.6%) <0.0001
Recurrent wheeze 21 (28.8%) 275 (5.5%) <0.0001
The OR for physician-diagnosed asthma among the subjects with repaired EA com-
pared with the control group was 4.1. Similarly, the OR for using asthma medica-
tion was 3.3, while the OR for recurrent wheeze was 6.9. However, when it came to 
allergic rhinitis or a family history of asthma, there was no statistically significant 
difference between the EA and control groups. Nor was there any statistically sig-
nificant difference in the prevalence of smokers or ex-smokers between the groups.
To make the study group as homogeneous as possible, the 63 subjects with the most 
common EA malformation (EA Gross type C, i. e. esophageal atresia with a dis-
tal tracheal fistula) were selected for further pulmonary investigations (Paper 3). 
Twenty-eight of the sixty-three (44%) eligible subjects agreed to undergo pulmonary 
functional testing and also completed the original questionnaire used in the previ-
ous study (Paper 2) to provide a current symptom assessment.
Only six of the 28 subjects tested (21%) had normal FEV1/FVC ratio, LCI and TLC 
results. The most common abnormality, found in 17 subjects (61%), was a raised 
LCI, indicating a peripheral airway obstruction. The second most common abnor-
mality was a reduced FEV1, seen in 14 subjects (50%). However, only six subjects 
demonstrated an abnormally reduced FEV1/FVC ratio, which indicates a central 
airway obstruction (Table 4).
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Table 4. Pulmonary function abnormalities among 28 adult EA subjects.  
Abnormal pulmonary function Number of patients (%)
Raised LCI 17 (61)
Reduced FEV1 14 (50)
Reduced FEV1/FVC 6 (21)
Reduced TLC 9 (32)
No consistent relationships were found between a history of respiratory symptoms 
and lung function abnormalities, probably due to the fact that the respiratory symp-
toms in our subjects were also common in the group of six patients with normal 
PFTs.
The Phadiatop was positive in 11 subjects, three of whom also had a positive bron-
chodilator response. FENO was elevated in six subjects, five of whom had a posi-
tive Phadiatop, but there was no statistically significant relationship between FENO 
and/or any lung function abnormality. 
The methacholine challenge test was positive in 17/22 (77%) of the investigated 
subjects and correlated to a positive Phadiatop as well as raised FENO.
The subjects with doctor-diagnosed asthma, 8/28 (29%), did not differ from the 
remainder in terms of symptoms, pulmonary function tests (Figure 7), Phadiatop, 
FENO or AHR.
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Figure 7. 
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Figure 7. Number of subjects with normal or abnormal lung function findings in relation 
to a history of doctor-diagnosed asthma (DDA). 
Esophageal symptoms and function (Papers 1 and 4)
The 69/79 (87%) subjects with the most common type of EA, Gross type C, were 
chosen for further esophageal investigations and 63/69 (91%) of them agreed to 
participate in the questionnaire study (Paper 1).
As many as 36/63 (57%) had swallowing difficulties to various degrees and, the 
higher the viscosity and solidity of the food, the more subjects reported symptoms 
of dysphagia. Data from previous hospital charts, or current smoking habits, weight, 
height or BMI were not able to give any explanation why these patients had dysphagia. 
Twenty patients (32%) reported heartburn and 25 (40%) had various degrees of 
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regurgitation. Multiple stepwise regression analysis showed an association between 
the dysphagia score and regurgitation, yielding an OR of 2.8 (95% CI: 1.2-6.6), but 
no such connection to heartburn was found.
There was no difference in QoL between the EA patients and the control group and 
the dysphagia score did not correlate statistically to the QoL.
Twenty-nine of the 63 (46%) subjects agreed to enter the study protocol which would 
evaluate their esophageal function (Paper 4). pH-MII was performed in 15/29, ma-
nometry was performed by 19/29 and 24/29 (83%) subjects were investigated with 
upper gastrointestinal endoscopy.
Eleven subjects (73%) displayed any pathological reflux variable measured by pH-
MII. The distribution between the different parameters is presented in Table 5.
Table 5. pH multichannel intraluminal impedance results in 15 adult subjects previously 
operated on for esophageal atresia.
pH/impedance monitoring, n=15 Results
(median, range)
Normal
value
Number 
abnormal
(%)
pH < 4 variables 
Acid reflux episodes, number 18 (1-81) ≤ 55 4 (27)
Acid exposure time (%)
– Total (RI) 0.7 (0-19.2) ≤ 4.2 2 (13)
– Upright 1 (0-7.3) ≤ 6.3 1 (7)
– Supine 0 (0-32.3) ≤ 1.2 4 (27)
 
Total number any abnormality pH < 4 5 (33)
pH > 4 variables
Weakly acidic reflux episodes, number 25 (5-80) ≤ 26 7 (47)
Weakly alkaline reflux episodes, number 1 (0-5) ≤ 1.0 6 (40)
Total number any abnormality pH > 4 10 (66)
Bolus exposure time (%) 0.6 (0-2.6) ≤1.4 3 (20)
There was a correlation between the number of weakly acidic reflux episodes and 
the numeric dysphagia score (p=0.023), while the other pH-MII parameters did not 
correlate to the score.
Neither heartburn nor regurgitation correlated statistically to pH-MII variables.
Manometry showed that most of the subjects, 14/19 (74%), had hypotonic wave 
amplitude in the distal esophagus. This finding correlated to non-propagating peri-
stalsis, which was registered in nine subjects (p=0.032) (Figures 8 and 9).
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Both upper and lower esophageal sphincter pressure were normal in the majority of 
the subjects (18/19 and 16/19 respectively). There was no correlation between dys-
phagia and esophageal motility.
Upper gastrointestinal endoscopy revealed 10/24 (42%) subjects with esophagitis, 
according to the LA classification. Histological esophagitis, according to Ismail-
Beigi classification, was present in 14/24 (58%), two of whom also had Barrett’s 
esophagus.(Figures 10 and 11). Esophagitis was associated with a raised RI and 
number of episodes of weakly acidic reflux ((p=0.028 and p=0.040 respectively) and 
tended to be related to the dysphagia score (p=0.052).  
The majority of the subjects had partial or complete LES incompetence (14 and 7 
respectively), which correlated to an increased number of acid reflux episodes and 
pathological RI (p=0.012 and 0.050 respectively). 
a
b
Figure 10. Esophageal squamous epithelium with thicker basal cell layer (a) and elongat-
ed papillae (b) which is characteristic for esophagitis. Arrow pointing at intraepithelial 
eosinophilic granulocyte. 
Figure 8. Manometry showing propagating 
peristalsis. 
Figure 9. Manometry showing non-propa-
gating peristalsis. 
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Figure 11. Esophageal biopsy with columnar lined epithelium including  intestinal meta-
plasia with goblet cells (Barrett’s esophagus).
Goblet cells
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General discussion
Since the first successful repair of a patient with EA, we currently have a high sur-
vival rate and a growing number of patients are reaching adulthood.
This study was mainly made up of two parts. In the first part (Papers 2 and 3), we 
based our results on symptoms and functional aspects of the lungs.  The second part 
(Papers 1 and 4) was structured in the same way but with respect to the esophagus. 
We found a high prevalence of respiratory symptoms in our EA group compared
with controls, including a diagnosis of asthma and the use of asthma medication. 
Our results are consistent with the largest population-based study of respiratory 
morbidity in adults with repaired EA (8). Even though we did not have data on the 
previous prevalence of respiratory symptoms in our EA cohort, our follow-up data 
did not indicate a reduction in prevalence with age, which has been stated by other 
investigators (8, 84). Twenty-eight subjects performed the pulmonary function tests 
(PFTs) and, even though only one had no reported symptom, we were unable to 
find a correlation between pulmonary function and respiratory symptoms. This has 
been noted before, even though previous studies have reported conflicting results 
(8, 115). The reason for this in our material was probably that respiratory symptoms 
were common, irrespective of normal or pathological pulmonary function tests. The 
pulmonary function tests revealed that as many as 22/28 (79%) of the subjects had 
pulmonary function test abnormality indicating an obstructive and/or restrictive 
disease. What was striking was that the majority of the subjects, 17/28, had abnor-
mal lung function, which was caused by peripheral airway obstruction. This has 
never been described before and would have been missed if only conventional spi-
rometry had been used. The reason for the pulmonary impairment is not known, but 
it is probably multifactorial, including both congenital (tracheomalacia, abnormal 
airway epithelium, defective vagal nerve) and acquired (gastro-esophageal reflux, 
postoperative restriction of the thorax) causes. 
In the literature, the prevalence of asthma among patients with EA varies between 
12% and 29%. We found a prevalence of 30% with doctor-diagnosed asthma 
(DDA), even though we did not see an over-representation of rhinitis or a family 
history of asthma, which is usually the case in subjects with asthma. Asthma-like 
symptoms, such as wheeze, attacks of breathlessness and long-standing cough, were 
very common among the EA subjects, which might make the asthma diagnosis diffi-
cult.  Among the subjects who performed the PFTs, we did not notice any difference 
between those with or without doctor-diagnosed asthma with respect to symptoms 
or PFT results, even though elevated FENO, positive Phadiatop and airway hyper-
responsiveness, typical in allergic asthma, were also common in our cohort (21%, 
39% and 77% respectively). However, the prevalence was similar in terms of the 
numbers of subjects in the groups with or without DDA. Taken together, these find-
ings raise the question of whether the diagnostic term “asthma” is correctly used in 
this patient group. Perhaps a diagnostic term such as “EA asthma” could prove use-
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ful in EA patients with asthma-like symptoms not fulfilling the criteria for classical 
asthma.
Dysphagia was seen to some extent in 57% of our patients, which is in accordance 
with most previous reports (3, 72). The definition when it comes to dysphagia varies 
in different studies and a comparison between studies and correlations to corre-
sponding factors might therefore be difficult. In an attempt to solve this problem, we 
used a numeric scoring system (96).  The prevalence of heartburn and regurgitation 
in our patient cohort was 32% and 40% respectively, which is in line with previous 
observations of the symptoms of GER (72, 74). By scoring dysphagia, we were able 
to find an association between dysphagia and regurgitation. Even though we focused 
on patients with Gross type C, using the dysphagia score enabled us to see a clear 
difference regarding dysphagia when we made a comparison with the often more 
complicated Gross type A. Twenty-nine subjects agreed to undergo further esopha-
geal investigations with pH-MII, esophageal manometry and upper gastrointestinal 
endoscopy (15/29, 19/29 and 24/29 subjects respectively completed the investiga-
tions).  To our knowledge, this is the first investigation in adults with repaired EA 
which has used pH-MII.  Interestingly, our data showed that the number of weakly 
acidic reflux episodes was related to dysphagia, which in turn tended to be more 
severe among patients with more severe mucosal injury. This correlation would have 
been missed if we had only used regular pH monitoring. However, even though 
esophageal dysmotility, which predisposes for dysphagia, was noted in the major-
ity of patients, we did not find a correlation to the dysphagia score. Eleven subjects 
(73%) displayed any pathological reflux variable measured with pH-MII, but nei-
ther heartburn nor regurgitation correlated statistically to pH-MII parameters, even 
though the subjects with regurgitation had a tendency to have more weakly acidic 
reflux episodes and increased bolus exposure time. This shows that merely symptom-
atology might not be enough to find those subjects with pathological GER. Among 
the patients with histologically proven esophagitis, 14/24 (58%), two of whom had 
Barrett’s esophagus, we found that there was a correlation with both increased RI 
and the number of episodes of weakly acidic reflux. The increased RI, as well as an 
increased number of acid reflux episodes, was also noted among those with an in-
competence of the lower esophageal sphincter. This is an interesting finding, since 
most studies of EA, including ours, have shown normal LES pressure in the major-
ity of subjects.  Our findings show that endoscopy, as well as pH-MII, appear to be 
important in the follow-up of EA patients.
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Conclusion and future considerations
Both esophageal and respiratory morbidity extends into adulthood to a considerable 
degree among adults with repaired EA. 
The pulmonary impairment appears to be greater than previously believed, espe-
cially in the peripheral lung. This stresses the importance of a close follow-up of lung 
function while the subjects are growing up. Since symptoms do not appear to predict 
the severity, the screening of lung function, including MBW, should be performed 
regularly, even though we are at present unable to say to which extent. The reason 
for pulmonary impairment is probably multifactorial, but early detection might help 
us properly to investigate and rule out, or treat, subclinical causes, such as micro-
aspiration or infections which can be treated. Future studies, which we plan, of both 
children and adults, might tell us whether there is a connection between a raised 
LCI and pathological pH-MII findings. When it comes to the asthma diagnosis, 
this must perhaps be reconsidered and instead referred to as “EA asthma” or some 
other suitable name.
Even though most pediatric surgeons agree that surveillance endoscopies should be 
performed in adults operated on for EA, there is no consensus on when or how often. 
This is especially true if the patient has no complaints. It is easy to understand that 
individuals with signs of GER require further surveillance, but we also noted that 
dysphagia tended to be correlated to the number of weakly acidic reflux episodes, 
which was in turn a factor predisposing for esophageal mucosal injury. This implies 
that not only those with signs of GER but also those with dysphagia should receive 
attention. Perhaps all the children leaving the pediatric community should perform 
both pH-MII and endoscopy in order to serve as an aid when it comes to planning 
future surveillance. 
Future studies are desirable in order to verify our results and establish guidelines for 
the surveillance of adults operated on for EA.

45
Sammanfattning på svenska
Sammanfattning på svenska
Esofagusatresi (EA) eller avbruten matstrupe är en medfödd missbildning som drab-
bar 1:3000 nyfödda barn. Orsaken är okänd och behandlingen är kirurgisk med en 
rekonstruktion av matstrupen. Missbildningen bidrar till att en hel del av patien-
terna besväras av problem som relateras till både matstrupen och luftvägarna. Dessa 
besvär följer ofta med upp i vuxen ålder.
Syftet med denna studie var att ta reda på hur mycket besvär som förekommer i 
vuxen ålder samt hur lung- och matstrupsfunktionen ter sig i olika mätningar samt 
om dessa mätningsresultat kan förklara besvären.  
Sjuttiotre av 80 överlevande patienter opererade i Göteborg mellan 1968-1983 för 
EA gick med på att delta i den första delen av studien som bestod av att svara på 
frågeformulär som handlade om symptom från luftvägarna och matstrupen. Tjugo-
nio av dessa patienter gick därefter med på att genomföra andra delen av studien 
vilken innefattade funktionsundersökningar av lungorna och matstrupen.
I frågeformulären framkom att dessa patienter överlag har en god livskvalité. Vi 
noterade dock att symptom både från luftvägarna och matstrupe var mycket van-
ligt förekommande. Femtiosju procent upplevde att de hade sväljningssvårigheter i 
varierande grad och detta verkade vara kopplat till besvär med uppstötningar, vilket 
noterades hos 40 %. Trettiotvå procent besvärades av halsbränna. Olika luftvägs-
symptom såsom väsningar och långvarig hosta var överrepresenterat när man jäm-
förde med allmänheten. Detta gällde även diagnosen astma, trots att inga kända 
riskfaktorer var överrepresenterade i patientgruppen jämfört med allmänheten. 
Lungfunktionsundersökningarna visade att så många som 79 % av de patienter som 
undersöktes hade en påverkad lungfunktion och att denna påverkan framförallt 
satt i de perifera delarna av lungan. Vi noterade även att överkänsliga luftvägar var 
mycket vanligt förekommande och förknippat med allergi och tecken på inflam-
mation i luftvägarna. Trots detta så fann vi inget samband mellan symptomen och 
lungundersökningarna. Vi kunde inte heller påvisa en skillnad mellan de som fått 
diagnosen astma och övriga, vare sig i undersökningsresultat eller i symptom. 
Matstrupsundersökningarna, pH och impedans, visade på en sjukligt ökad förekomst 
av uppstötningar från magsäcken. Tack vare impedansmätningen så kunde vi även 
registrera de uppstötningar som var svagt sura eller basiska (pH > 4), vilka domin-
erade (noterades hos 66 % av patienterna). Denna typ av uppstötning korrelerade till 
sväljnings-svårigheter men även till skada på matstrupens slemhinna. Inte oväntat 
fanns också ett samband mellan skada på matstrupens slemhinna och sura uppstötnin-
gar (pH < 4). Skada på matstrupens slemhinna noterades via gastroskopi hos 14/24 
patienter varav 2 stycken även hade en annan typ av slemhinna som normalt ses i 
tarmen, talande för en allvarlig slemhinneskada.
Både luftvägs- och matstrupssymptom är mycket vanligt hos vuxna individer oper-
erade för EA. Lungfunktionen tycks mer påverkad än vad som tidigare varit känt 
och uppstötningar med pH värden både över och under 4 verkar kunna bidra till 
matstrupsbesvär samt slemhinneskada. Astma verkar vara svårt att diagnostisera i 
denna patientgrupp eftersom symptomen är svårtolkade. Sammantaget visar denna 
studie på vikten av fortsatt uppföljning av denna patientgrupp även i vuxen ålder. 
46
47
Acknowledgements
Acknowledgements
To all the individuals who participated in this study and made it possible.
Lars-Göran Friberg, who introduced me to esophageal surgery and has always be-
lieved in, and supported, me. The best teacher anyone could ask for.
Ulla Sillén, my scientific tutor, who has been a tremendous support and has encour-
aged and stimulated me with skillful scientific expertise.
Linus Jönsson, my wingman in pediatric surgery, a true friend who always stands 
up for me.  
Göran Wennergren, for his immense kindness, wise thoughts and support through 
the whole process. 
Per Gustafsson, for his devotion, expertise and willingness to help me even during 
summer evenings at his cottage.
Anders Eriksson, for his excellent help and enthusiasm with the endoscopic inves-
tigation.
Kate Abrahamsson, for encouraging research, and making it possible, in a busy 
clinical environment.
Cathrine Johansson, Gunnar Göthberg, Linda Ekerljung, Staffan Redfors, 
Birgitta Houltz and Olof Andersson, my other co-authors for their contribution 
to this thesis.
Liselotte Steen Bergström, for all her kind help with the histopathological exami-
nations.
Tina Linnér and Monica Rosberg, for their expertise, cheerfulness and amazing 
will always to assist when it comes to performing investigations at the Department 
of Pediatric Clinical Physiology.
Ann-Christine Mjörnheim, for her skillfulness, assistance, cakes and friendliness.
Annika Hövner, for her detective skills at the beginning of this study.
Bengt Bengtsson, Aldina Pivodic and Nils-Gunnar Pehrsson at Statistiska kon-
sultgruppen, for assisting me with the statistics.
Soffi Petersson, SU/Fotografik, for swift, professional help with layout, graphics 
and pictures.
The entire “Gastro Team”, for their support and cheering.
All colleagues, friends and personnel at the Department of Pediatric Surgery, who 
I have the privilege to work with.
My brother, for his support when I need it.
My parents, who have always been there for me, both in my private life and profes-
sionally.
My beloved Cathrine and children, Victor, Oscar, Stella and Walter, who make 
my day, every day.
48
49
References
References
1. Lilja HE, Wester T. Outcome in neonates with esophageal atresia treated over the last 20 
years. Pediatr Surg Int. 2008 May;24(5):531-6.
2. Koivusalo AI, Pakarinen MP, Rintala RJ. Modern outcomes of oesophageal atresia: single 
centre experience over the last twenty years. J Pediatr Surg. 2013 Feb;48(2):297-303.
3. Rintala RJ, Sistonen S, Pakarinen MP. Outcome of esophageal atresia beyond childhood. 
Semin Pediatr Surg. 2009 Feb;18(1):50-6.
4. Deurloo JA, Klinkenberg EC, Ekkelkamp S, Heij HA, Aronson DC. Adults with cor-
rected oesophageal atresia: is oesophageal function associated with complaints and/
or quality of life? Pediatr Surg Int. 2008 May;24(5):537-41.
5. Sistonen SJ, Koivusalo A, Nieminen U, Lindahl H, Lohi J, Kero M, Kärkkäinen PA, 
Färkkilä MA, Sarna S, Rintala RJ, Pakarinen MP. Esophageal morbidity and func-
tion in adults with repaired esophageal atresia with tracheoesophageal fistula: a pop-
ulation-based long-term follow-up. Ann Surg. 2010 Jun;251(6):1167-73.
6. Kovesi T, Rubin S. Long-term complications of congenital esophageal atresia and/or tra-
cheoesophageal fistula. Chest. 2004 Sep;126(3):915-25.
7. Malmström K, Lohi J, Lindahl H, Pelkonen A, Kajosaari M, Sarna S, Malmberg LP, 
Mäkelä MJ. Longitudinal follow-up of bronchial inflammation, respiratory symp-
toms, and pulmonary function in adolescents after repair of esophageal atresia with 
tracheoesophageal fistula. J Pediatr. 2008 Sep;153(3):396-401.
8. Sistonen S, Malmberg P, Malmström K, Haahtela T, Sarna S, Rintala RJ, Pakarinen 
MP. Repaired oesophageal atresia: respiratory morbidity and pulmonary function in 
adults. Eur Respir J. 2010 Nov;36(5):1106-12.
9. LeSouëf PN, Myers NA, Landau LI. Etiologic factors in long-term respiratory function 
abnormalities following esophageal atresia repair. J Pediatr Surg. 1987 Oct;22(10):918-22.
10. Gibson T. The Anatomy of Humane Bodies Epitomized. 6th ed. Awnsham and Churchill 
(London), 240-242, 1703.
11. Ladd WE. The surgical treatment of esophageal atresia and tracheoesophageal fistulas. 
N Engl J Med 1944;230:625-637.
12. Leven NL. Congenital atresia of the esophagus with tracheoesophageal fistula. J Thorac 
Surg 1941;10:648-657.
13. Haight C, Towsley HA. Congenital atresia of esophagus with tracheoesophageal fistula. 
Extrapleural ligation and end-to end anastomosis of esophageal segments. Surg Gy-
necol Obstet 1943;76:672-688.
14. Sandblom P. The treatment of congenital atresia of the esophagus from a technical point 
of view. Acta Chir Scand. 1948 Sep 30;97(1):25-34.
15. El-Gohary Y, Gittes GK, Tovar JA. Congenital anomalies of the esophagus. Semin Pedi-
atr Surg. 2010 Aug;19(3):186-93.
16. Diez-Pardo JA, Baoquan Q, Navarro C, Tovar JA. A new rodent experimental model of 
esophageal atresia and tracheoesophageal fistula: preliminary report. J Pediatr Surg. 
1996 Apr;31(4):498-502.
17. Qi BQ, Merei J, Farmer P, Hasthorpe S, Myers NA, Beasley SW, Hutson JM. The vagus 
and recurrent laryngeal nerves in the rodent experimental model of esophageal atre-
sia. J Pediatr Surg. 1997 Nov;32(11):1580-6.
18. Liu XM, Aras-Lopez R, Martinez L, et al: Abnormal development of lung innervation in 
experimental esophageal atresia. Eur J Pediatr Surg 2012;22:67-73. 
19. Qi BQ, Merei J, Farmer P, Hasthorpe S, Hutson JM, Myers NA, Beasley SW. Tracheo-
50
References
malacia with esophageal atresia and tracheoesophageal fistula in fetal rats. J Pediatr 
Surg. 1997 Nov;32(11):1575-9.
20. Xia H, Otten C, Migliazza L, et al: Tracheobronchial malformations in experimental 
esophageal atresia. J Pediatr Surg  1999;34:536-539.
21. Fragoso AC, Aras-Lopez R, Martinez L, et al: Abnormal control of lung branching in 
experimental esophageal atresia. Pediatr Surg Int 2013;29:171-7.
22. Oddsberg J. Environmental factors in the etiology of esophageal atresia. J Pediatr Gas-
troenterol Nutr. 2011 May;52 Suppl 1:S4-5.
23. Bednarczyk D, Sasiadek MM, Smigiel R. Chromosome Aberrations And Gene Muta-
tions In Patients With Esophageal Atresia. J Pediatr Gastroenterol Nutr. 2013 Dec; 
57(6):688-93.
24. Spitz L. Esophageal atresia. Lessons I have learned in a 40-year experience. J Pediatr 
Surg. 2006 Oct;41(10):1635-40.
25. Oddsberg J, Lu Y, Lagergren J. Aspects of esophageal atresia in a population-based set-
ting: incidence, mortality, and cancer risk. Pediatr Surg Int. 2012 Mar;28(3):249-57.
26. Harris J, Källén B, Robert E. Descriptive epidemiology of alimentary tract atresia. Tera-
tology. 1995 Jul;52(1):15-29.
27. Orford J, Glasson M, Beasley S, Shi E, Myers N, Cass D. Oesophageal atresia in twins. 
Pediatr Surg Int. 2000;16(8):541-5.
28. Oddsberg J, Jia C, Nilsson E, Ye W, Lagergren J. Influence of maternal parity, age, and 
ethnicity on risk of esophageal atresia in the infant in a population-based study. J 
Pediatr Surg. 2008 Sep;43(9):1660-5.
29. Vogt EC. Congenital esophageal atresia. Am J Roentgenol 1929;22:463-465.
30. Gross RE. The surgery of infancy and childhood. Philadelphia, WB Saunders 1953:76
31. Kluth D. Atlas of esophageal atresia. J Pediatr Surg. 1976 Dec;11(6):901-19
32. Waterston DJ, Carter RE, Aberdeen E.  Oesophageal atresia: tracheo-oesophageal fis-
tula. A study of survival in 218 infants. Lancet. 1962 Apr 21;1(7234):819-22
33. Poenaru D, Laberge JM, Neilson IR, Guttman FM. A new prognostic classification for 
esophageal atresia. Surgery. 1993 Apr;113(4):426-32.
34. Spitz L, Kiely EM, Morecroft JA, Drake DP. Oesophageal atresia: at-risk groups for the 
1990s. J Pediatr Surg. 1994 Jun;29(6):723-5.
35. Yagyu M, Gitter H, Richter B, Booss D Esophageal atresia in Bremen, Germany--eval-
uation of preoperative risk classification in esophageal atresia. J Pediatr Surg. 2000 
Apr;35(4):584-7.
36. Deurloo JA, de Vos R, Ekkelkamp S, Heij HA, Aronson DC. Prognostic factors for 
mortality of oesophageal atresia patients: Waterston revived. Eur J Pediatr. 2004 
Oct;163(10):624-5
37. Spitz L. Oesophageal atresia. Orphanet J Rare Dis. 2007 May 11;2:24. Review.
38. Chittmittrapap S, Spitz L, Kiely EM, Brereton RJ. Oesophageal atresia and associated 
anomalies. Arch Dis Child. 1989 Mar;64(3):364-8.
39. Keckler SJ, St Peter SD, Valusek PA, Tsao K, Snyder CL, Holcomb GW 3rd, Ostlie DJ. 
VACTERL anomalies in patients with esophageal atresia: an updated delineation of 
the spectrum and review of the literature. Pediatr Surg Int. 2007 Apr;23(4):309-13
40. Stringer MD, McKenna KM, Goldstein RB, Filly RA, Adzick NS, Harrison MR. Prena-
tal diagnosis of esophageal atresia. J Pediatr Surg. 1995 Sep;30(9):1258-63.
41. Stoll C, Alembik Y, Dott B, Roth MP. Evaluation of prenatal diagnosis of congenital 
gastro-intestinal atresias. Eur J Epidemiol. 1996 Dec;12(6):611-6.
42. Shulman A, Mazkereth R, Zalel Y, Kuint J, Lipitz S, Avigad I, Achiron R. Prenatal iden-
tification of esophageal atresia: the role of ultrasonography for evaluation of func-
tional anatomy. Prenat Diagn. 2002 Aug;22(8):669-74.
51
References
43. Mortell AE, Azizkhan RG. Esophageal atresia repair with thoracotomy: the Cincinnati 
contemporary experience. Semin Pediatr Surg. 2009 Feb;18(1):12-9.
44. Burge DM, Shah K, Spark P, Shenker N, Pierce M, Kurinczuk JJ, Draper ES, Johnson 
PR, Knight M; British Association of Paediatric Surgeons Congenital Anomalies 
Surveillance System (BAPS-CASS). Contemporary management and outcomes for 
infants born with oesophageal atresia. Br J Surg. 2013 Mar;100(4):515-21.
45. Atzori P, Iacobelli BD, Bottero S, Spirydakis J, Laviani R, Trucchi A, Braguglia A, Bago-
lan P. Preoperative tracheobronchoscopy in newborns with esophageal atresia: does 
it matter? J Pediatr Surg. 2006 Jun;41(6):1054-7.
46. Lal D, Miyano G, Juang D, Sharp NE, St Peter SD. Current patterns of practice and 
technique in the repair of esophageal atresia and tracheoesophageal fistua: an IPEG 
survey. J Laparoendosc Adv Surg Tech A. 2013 Jul;23(7):635-8.
47. Lobe TE, Rothenberg SS, Waldschmidt J, et al: Thoracoscopic repair of esophageal atre-
sia in an infant: A surgical first. Pediatr Endosurg Innovative Tech 1999;3:141-148. 
48. Borruto FA, Impellizzeri P, Montalto AS, Antonuccio P, Santacaterina E, Scalfari G, 
Arena F, Romeo C.: Thoracoscopy versus thoracotomy for esophageal atresia and 
tracheoesophageal fistula repair: review of the literature and meta-analysis. Eur J 
Pediatr Surg. 2012 Dec;22(6):415-9.
49. Laberge JM, Blair GK. Thoracotomy for repair of esophageal atresia: not as bad as they 
want you to think! Dis Esophagus. 2013 May-Jun;26(4):365-71.
50. Babu R, Pierro A, Spitz L, Drake DP, Kiely EM. The management of oesophageal atresia 
in neonates with right-sided aortic arch. J Pediatr Surg. 2000 Jan;35(1):56-8.
51. Wood JA, Carachi R. The right-sided aortic arch in children with oesophageal atresia and 
tracheo-oesophageal fistula. Eur J Pediatr Surg. 2012 Feb;22(1):3-7.
52. Allen SR, Ignacio R, Falcone RA, Alonso MH, Brown RL, Garcia VF, Inge TH, Ryck-
man FC, Warner BW, Azizkhan RG, Tiao GM. The effect of a right-sided aortic 
arch on outcome in children with esophageal atresia and tracheoesophageal fistula. J 
Pediatr Surg. 2006 Mar;41(3):479-83.
53. Bicakci U, Tander B, Ariturk E, Rizalar R, Ayyildiz SH, Bernay F. The right-sided aor-
tic arch in children with esophageal atresia and tracheo-esophageal fistula: a repair 
through the right thoracotomy. Pediatr Surg Int. 2009 May;25(5):423-5.
54. Bianchi A, Sowande O, Alizai NK, Rampersad B. Aesthetics and lateral thoracotomy in 
the neonate. J Pediatr Surg. 1998 Dec;33(12):1798-800.
55. Singh SJ, Kapila L. Denis Browne's thoracotomy revised. Pediatr Surg Int. 2002 
Mar;18(2-3):90-2.
56. Livaditis A, Rådberg L, Odensjö G. Esophageal end-to-end anastomosis. Reduction 
of anastomotic tension by circular myotomy. Scand J Thorac Cardiovasc Surg. 
1972;6(2):206-14.
57. Gough MH. Esophageal atresia--use of an anterior flap in the difficult anastomosis. J 
Pediatr Surg. 1980 Jun;15(3):310-1.
58. Foker JE, Linden BC, Boyle EM Jr, Marquardt C. Development of a true primary re-
pair for the full spectrum of esophageal atresia. Ann Surg. 1997 Oct;226(4):533-41; 
discussion 541-3.
59. Ron O, De Coppi P, Pierro A. The surgical approach to esophageal atresia repair 
and the management of long-gap atresia: results of a survey. Semin Pediatr Surg 
2009;18(1):44-9.
60. Spitz L, Kiely EM, Drake DP, Pierro A. Long-gap oesophageal atresia. Pediatr Surg Int. 
1996 Aug;11(7):462-5.
61. Cusick EL, Batchelor AA, Spicer RD. Development of a technique for jejunal interposi-
tion in long-gap esophageal atresia. J Pediatr Surg. 1993 Aug;28(8):990-4.
52
References
62. Dickson JA. Esophageal substitution with colon - the Waterston operation. Pediatr Surg 
Int. 1996 Apr;11(4):224-6.
63. Spitz L. Gastric transposition via the mediastinal route for infants with long-gap esopha-
geal atresia. J Pediatr Surg. 1984 Apr;19(2):149-54.
64. Schärli AF. Esophageal reconstruction by elongation of the lesser gastric curvature. Pe-
diatr Surg Int. 1996 Apr;11(4):214-7.
65. Randolph JG. The reversed gastric tube for esophageal replacement in children. Pediatr 
Surg Int. 1996 Apr;11(4):221-3.
66. Nakahara Y, Aoyama K, Goto T, Iwamura Y, Takahashi Y, Asai T. Modified Col-
lis-Nissen procedure for long gap pure esophageal atresia. J Pediatr Surg. 2012 
Mar;47(3):462-6.
67. Gallo G, Zwaveling S, Groen H, Van der Zee D, Hulscher J. Long-gap esophageal atre-
sia: a meta-analysis of jejunal interposition, colon interposition, and gastric pull-up. 
Eur J Pediatr Surg. 2012 Dec;22(6):420-5.
68. Zhao R, Li K, Shen C, Zheng S. The outcome of conservative treatment for anasto-
motic leakage after surgical repair of esophageal atresia. J Pediatr Surg. 2011 
Dec;46(12):2274-8.
69. Holcomb GW 3rd, Rothenberg SS, Bax KM, Martinez-Ferro M, Albanese CT, Ostlie DJ, 
van Der Zee DC, Yeung CK. Thoracoscopic repair of esophageal atresia and tracheo-
esophageal fistula: a multi-institutional analysis. Ann Surg. 2005 Sep;242(3):422-8; 
discussion 428-30.
70. Richter GT, Ryckman F, Brown RL, Rutter MJ. Endoscopic management of recurrent 
tracheoesophageal fistula. J Pediatr Surg. 2008 Jan;43(1):238-45.
71. Bruch SW, Hirschl RB, Coran AG. The diagnosis and management of recurrent tracheo-
esophageal fistulas. J Pediatr Surg. 2010 Feb;45(2):337-40.
72. Chetcuti P, Myers NA, Phelan PD, Beasley SW. Adults who survived repair of con-
genital oesophageal atresia and tracheo-oesophageal fistula. BMJ. 1988 Jul 
30;297(6644):344-6.
73. Tovar JA, Diez Pardo JA, Murcia J, Prieto G, Molina M, Polanco I. Ambulatory 24-hour 
manometric and pH metric evidence of permanent impairment of clearance capacity 
in patients with esophageal atresia. J Pediatr Surg. 1995 Aug;30(8):1224-31.
74. Deurloo JA, Ekkelkamp S, Bartelsman JF, Ten Kate FJ, Schoorl M, Heij HA, Aronson 
DC. Gastroesophageal reflux: prevalence in adults older than 28 years after correc-
tion of esophageal atresia. Ann Surg. 2003 Nov;238(5):686-9.
75. Little DC, Rescorla FJ, Grosfeld JL, West KW, Scherer LR, Engum SA. Long-term 
analysis of children with esophageal atresia and tracheoesophageal fistula. J Pediatr 
Surg. 2003 Jun;38(6):852-6.
76. Taylor AC, Breen KJ, Auldist A, Catto-Smith A, Clarnette T, Crameri J, Taylor R, Naga-
rajah S, Brady J, Stokes K. Gastroesophageal reflux and related pathology in adults 
who were born with esophageal atresia: a long-term follow-up study. Clin Gastroen-
terol Hepatol. 2007 Jun;5(6):702-6.
77. Tovar JA, Fragoso AC. Anti-reflux surgery for patients with esophageal atresia. Dis 
Esophagus. 2013 May-Jun;26(4):401-4.
78. Schneider A, Michaud L, Gottrand F. Esophageal atresia: metaplasia, Barrett. Dis 
Esophagus. 2013 May-Jun;26(4):425-7.
79. Voltaggio L, Montgomery EA, Lam-Himlin D. A clinical and histopathologic focus 
on Barrett esophagus and Barrett-related dysplasia. Arch Pathol Lab Med. 2011 
Oct;135(10):1249-60.
80. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and 
who is at risk? Gut. 2005 Mar;54 Suppl 1:i1-5.
53
References
81. Jayasekera CS, Desmond PV, Holmes JA, Kitson M, Taylor AC. Cluster of 4 cases of 
esophageal squamous cell cancer developing in adults with surgically corrected 
esophageal atresia--time for screening to start. J Pediatr Surg. 2012 Apr;47(4):646-51.
82. Sistonen SJ, Koivusalo A, Lindahl H, Pukkala E, Rintala RJ, Pakarinen MP. Cancer 
after repair of esophageal atresia: population-based long-term follow-up. J Pediatr 
Surg. 2008 Apr;43(4):602-5.
83. Kovesi T. Long-term respiratory complications of congenital esophageal atresia with 
or without tracheoesophageal fistula: an update. Dis Esophagus. 2013 May-
Jun;26(4):413-6.
84. Chetcuti P, Phelan PD. Respiratory morbidity after repair of oesophageal atresia and 
tracheo-oesophageal fistula. Arch Dis Child. 1993 Feb;68(2):167-70.
85. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The 
Montreal definition and classification of gastroesophageal reflux disease: a global 
evidence-based consensus. Am J Gastroenterol. 2006 Aug;101(8):1900-20.
86. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal 
reflux disease: a systematic review. Gut. 2005 May;54(5):710-7.
87. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterologi-
cal Association. American Gastroenterological Association technical review on the 
management of Barrett’s esophagus. Gastroenterology. 2011;140(3):e18-e52.
88. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel 
P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman E, Bhandari P, Jankowski 
JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de 
Caestecker J. British Society of Gastroenterology guidelines on the diagnosis and 
management of Barrett's oesophagus. Gut. 2014 Jan;63(1):7-42
89. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth 
M, Stolte M, Talley NJ, Agréus L. Prevalence of Barrett's esophagus in the general 
population: an endoscopic study Gastroenterology. 2005 Dec;129(6):1825-31.
90. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand 
BY, Winchester CC, Roda E, Bazzoli F. Gastro-oesophageal reflux symptoms, oe-
sophagitis and Barrett's oesophagus in the general population: the Loiano-Monghi-
doro study.Gut. 2008 Oct;57(10):1354-9.
91. Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findings among 
50-79-year-old men and women in an urban population. Dysphagia. 1991;6(4):187-92.
92. Macklem PT. The physiology of small airways. Am J Respir Crit Care Med. 1998 
May;157(5 Pt 2): S181-3.
93. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet LP. Global 
asthma prevalence in adults: findings from the cross-sectional world health survey. 
BMC Public Health. 2012 Mar 19;12:204.
94. Lötvall J, Ekerljung L, Rönmark EP, Wennergren G, Lindén A, Rönmark E, Torén K, 
Lundbäck B. West Sweden Asthma Study: prevalence trends over the last 18 years 
argues no recent increase in asthma. Respir Res. 2009 Oct 12;10:94.
95. Dakkak M, Bennett JR. A new dysphagia score with objective validation. J Clin Gastro-
enterol 1992; 14(2): 99-100.
96. Watson DI, Pike GK, Baigrie RJ, et al. Prospective double-blind randomized trial of 
laparoscopic Nissen fundoplication with division and without division of short gas-
tric vessels. Ann Surg 1997; 226(5): 642-52.
97. Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagno-
sis and management of gastro-oesophageal reflux disease in primary care. Aliment 
Pharmacol Ther 2009; 30(10): 1030-8.
98. Taft C, Karlsson J, Sullivan M. Performance of the Swedish SF-36 version 2.0. Qual Life 
54
References
Res 2004; 13(1): 251-6.
99. Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in north-
ern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991; 4: 
257-66.
100. Gustafsson PM, Aurora P, Lindblad A: Evaluation of ventilation maldistribution 
as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 
2003;22:972-979. 
101. Robinson PD, Latzin P, Verbanck S, et al: Consensus statement for inert gas washout 
measurement using multiple- and single- breath tests. Eur Respir J 2013;41:507-522.
102. Miller MR, Hankinson J, Brusasco V, et al: Standardisation of spirometry. Eur Respir 
J  2005; 26:319-338.
103. Stanojevic S, Wade A, Stocks J, et al: Reference ranges for spirometry across all ages: a 
new approach. Am J Respir Crit Care Med 2008;177:253-260. 
104. Wanger J, Clausen JL, Coates A, et al: Standardisation of the measurement of lung 
volumes. Eur Respir J  2005;26:511-522.
105. Hedenstrom H, Malmberg P, Agarwal K: Reference values for lung function tests in 
females. Regression equations with smoking variables. Bull Eur Physiopathol Respir 
1985;21:551-557. 
106. Hedenstrom H, Malmberg P, Fridriksson HV: Reference values for lung function tests 
in men: regression equations with smoking variables. Ups J Med Sci  1986;91:299-310.
107. ATS/ERS recommendations for standardized procedures for the online and offline 
measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. 
Am J Respir Crit Care Med 2005;171:912-930. 
108. Olin AC, Bake B, Toren K: Fraction of exhaled nitric oxide at 50 mL/s: reference values 
for adult lifelong never-smokers. Chest 2007;131:1852-1856. 
109. Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, Zhang X, Adhami T, Murray J, 
Peters J, Castell D. Twenty-four hour ambulatory simultaneous impedance and pH 
monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J 
Gastroenterol. 2004 Jun;99(6):1037-43.
110. Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esopha-
gus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974 
Oct;62(4):325-32.
111. Lundell L, Abrahamsson H, Ruth M, Sandberg N, Olbe LC. Lower esophageal sphinc-
ter characteristics and esophageal acid exposure following partial or 360 degrees 
fundoplication: results of a prospective, randomized, clinical study. World J Surg. 
1991 Jan-Feb;15(1):115-20.
112. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut. 
2001 Jul;49(1):145-51.
113. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, 
Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L. Endoscopic assessment 
of oesophagitis: clinical and functional correlates and further validation of the Los 
Angeles classification. Gut. 1999 Aug;45(2):172-80.
114. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal 
reflux in man. Gastroenterology. 1970 Feb;58(2): 163-174.
115. Chetcuti P, Phelan PD, Greenwood R. Lung function abnormalities in repaired oe-
sophageal atresia and tracheo-oesophageal fistula. Thorax. 1992 Dec;47(12):1030-4.
